About 100 reports

Generic Drugs Imports and Exports

  • Generic Drug
  • China
  • Prescription Drug Sales
  • Industrial Production

Generic Drugs Market

4297 4900 3822

Generic Drugs Market Research Report: By Type (Simple, Super, Biosimilars), Application (Neurological Diseases, Cardiological Diseases, Metabolic Diseases, Infectious Diseases, Orthopedic Diseases, Genitourinary/Hormonal Diseases, Respiratory Diseases), Route of Administration (Oral, Injection, Cutaneous, Mucosal, Inhalation), Distribution...

  • Generic Drug
  • World

Report Scope This report discusses the implications of all the above-mentioned trends in the context of the current size and growth of the market for generic drugs, both in global terms and broken down by the most important national markets.The nature and structure of the generic drug industry is discussed, with profiles...

  • Generic Drug
  • World

Abstract: - Global Generic Drugs Market to Reach $535.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Generic Drugs estimated at US$286 Billion in the year 2020, is projected to reach a revised size of US$535.5 Billion by 2027, growing at aCAGR of 9.4% over the period 2020-2027. Pure Generic Drugs,...

  • Generic Drug
  • World
  • China
  • United States

Generic Drugs Market Report 2020-2030: Growth in Leading Regional and National Markets (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan,...

  • Generic Drug
  • World
  • APAC
  • Health Expenditure
  • Generics Use

Forecasts by Drug Class (Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Others), by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Others), by Patient Demographics (Adult Patient, Paediatric Patient, Geriatric Patient), by End-user (Homecare, Hospitals, Specialty...

  • Cough And Cold
  • Nasal Drug Delivery
  • Generic Drug
  • APAC
  • World
  • Europe
  • Latin America
  • Generic Drugs Market Share

Abstract: - Global Inhalation and Nasal Spray Generic Drugs Market to Reach $38 Billion by 2027 - Amid the COVID-19 crisis, the global market for Inhalation and Nasal Spray Generic Drugs estimated at US$26.6 Billion in the year 2020, is projected to reach a revised size of US$38 Billion by 2027, growing at a CAGR of...

  • Cough And Cold
  • Nasal Drug Delivery
  • Generic Drug
  • Allergy Drug
  • World
  • China
  • United States

United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the...

  • Generic Drug
  • United States
  • Generics Use
  • Health Expenditure

Inhalation and Nasal Spray Generic Drugs Market Report Overview Inhalation and Nasal Spray Generic Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Inhalation and Nasal Spray Generic Drugs market types and applications. It is a...

  • Cough And Cold
  • Nasal Drug Delivery
  • Generic Drug
  • World
  • Health Provider Density

The global generic drugs market reached a value of US$ 386 Billion in 2020. A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect,...

  • Generic Drug
  • World
  • Drug Approval

Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing...

  • Generic Drug
  • World
  • Chronic Disease Prevalence
  • Diabetes Prevalence

Global Generic Drugs Market 2020-2024 The analyst has been monitoring the generic drugs market and it is poised to grow by $ 123.50 mn during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers,...

  • Generic Drug
  • World

2020 Generic Drugs: Leading Companies Capabilities, Goals and Strategies This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors. The...

  • Generic Drug
  • Research And Development
  • World

2021 Leading Generic Drug Companies SWOT Analysis--Capabilities, Goals and Strategies This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading...

  • Generic Drug
  • Research And Development
  • World

North America, Europe, India, Rest of the World (RoW) The top 10 generic drug producers have 61% share of the total revenue made by these top 50 companies. 22% of the top 50 generic drug producers are in North America. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing...

  • Generic Drug
  • World
  • Generic Drugs Market Share

"Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026" Report Highlights: • Global Cancer Generics Market Trend Analysis • Global Cancer Generics Market Opportunity: > USD 55 Billion By 2026 • Global Generics Market Growth 2018-2026: > 130% • Global Cancer Generics Market Growth 2018-2026: 200% •...

  • Generic Drug
  • World
  • Cancer Mortality

The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...

  • Healthcare
  • Generic Drug
  • Oncology
  • Research And Development
  • Diagnostics
  • Health Services
  • Cancer Diagnostics
  • World

Generic Drugs: Leading Companies Capabilities, Goals and Strategies This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the...

  • Generic Drug
  • Research And Development
  • World

Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria.With African governments facing major health financing challenges, a significant...

  • Pharmaceutical
  • Generic Drug
  • Kenya
  • Africa

Generic Drugs Industry Overview

  • Generic Drug
  • China
  • Employment Costs
  • Prescription Drug Sales

Generic Drugs Imports and Exports

  • Generic Drug
  • China
  • Prescription Drug Sales
  • Industrial Production

Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug...

  • Generic Drug
  • Canada
  • Health Expenditure
  • Chronic Disease Prevalence

Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of...

  • Generic Drug
  • Brazil
  • Generic Drugs Market Share
  • Generics Use

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in japan was...

  • Generic Drug
  • Japan
  • Generic Drugs Market Share
  • Drug Approval

The GCC generic drug market reached a value of US$ 3.94 Billion in 2020. Generic drugs are bioequivalent of branded medicines, which have similar dosages, risks, effects, side effects, strengths, intended use and route of administration. They also have identical active ingredients and are relatively less expensive than their branded counterparts,...

  • Generic Drug
  • GCC
  • Pharmaceutical Production

This research service analyzes the European market for chromatography instruments and covers gas, liquid, and ion chromatography technologies/instruments.Germany, the United Kingdom, France, Italy, Switzerland, Russia, Benelux, Scandinavia, and the rest of Europe (ROE) countries are the regions included in the scope of this research. Benelux...

  • Laboratory Equipment
  • Oil And Gas
  • Proteomics
  • Generic Drug
  • Europe

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D...

  • Research And Development
  • Generic Drug
  • Anti-Infective
  • Parenteral Nutrition
  • In-Store Retail
  • Chronic Disease
  • Pharmacy
  • Cardiology
  • World

Abstract: - Growing Competition in Consumer Markets, Plethora of Products With Myriad Claims Means Consumers Increasingly Want Proof of Efficacy. Efficacy Testing to Reach $866.3 Billion - The global market for Efficacy Testing is projected to reach US$866.3 million by the year 2027, trailing a post COVID-19 CAGR...

  • Pharmaceutical
  • Generic Drug
  • Cosmetics
  • World
  • Health Insurance Claims
  • Drug Approval

INTRODUCTION In 2018, it was estimated that the availability of low-cost, generic versions of pharmaceutical interventions saved nearly USD 1.6 trillion in healthcare costs in the US over the last decade. Given the cost benefits offered, generic medicines usually have high adoption rates. Moreover, upcoming patent expiries...

  • Pharmaceutical
  • Generic Drug
  • APAC
  • North America
  • United States
  • Europe
  • South America
  • Middle East
  • Africa
  • Drug Approval

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2011-2018, the US generic drug market grew at a CAGR of 12% and currently...

  • Generic Drug
  • United States
  • Chronic Disease Prevalence
  • Health Expenditure